Difference between revisions of "Hoffmann M, et al, Cell (2020), cited as Ref 23 in DOI:10.1007/s11886-020-01292-3 (Q10532)"
Jump to navigation
Jump to search
(Created claim: Published In Name String (P102): Cell, #quickstatements; #temporary_batch_1592505200825) |
(Added link to [sliswiki]: Hoffmann M, et al, Cell (2020), cited as Ref 23 in DOI:10.1007/s11886-020-01292-3, #quickstatements; #temporary_batch_1592946843269) |
||
| links / sliswiki / name | links / sliswiki / name | ||
| + | |||
Latest revision as of 21:14, 23 June 2020
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Hoffmann M, et al, Cell (2020), cited as Ref 23 in DOI:10.1007/s11886-020-01292-3
|
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
|
Statements
Q10356 (Deleted Item)
0 references
SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor article SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor (English)
0 references
Hoffmann M
0 references
Kleine-Weber H
0 references
Schroeder S
0 references
Mu MA
0 references
Drosten C
0 references
Po S
0 references
2020
0 references
Cell
0 references
